Keywords: unit, mcneil, deal, icagen, ica-17043, johnson, consumer
J&J unit McNeil in deal with Icagen for ICA-17043
Article | 05 July 2004
Johnson & Johnson's McNeil Consumer & Specialty Pharmaceuticals hasentered into a development and commercialization agreement with Icagen for ICA-17043, a novel once-a-day ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
